Yi-Wen Tsai

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingDisease surveillanceGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 11, 2026
Battle against time for innovative cancer treatment: an updated cost-effectiveness analysis of pemigatinib in intrahepatic cholangiocarcinoma.

I-Ting Wang, Hsiao-Lin Chen, Wei-Ming Huang

|Jan 15, 2026
Cost-effectiveness of lenvatinib plus pembrolizumab as the second-line treatment for advanced endometrial carcinoma.

Szu-Ting Chiang, Chen-Han Chueh, Yu-Wen Wen

|Oct 27, 2025
Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan.

Wei-Ming Huang, Chen-Han Chueh, Chien-Yu Tseng

|Oct 16, 2025
The Cost-Effectiveness of Sugemalimab Plus CAPOX in Treating Advanced Gastric Cancer: Analysis from the GEMSTONE-303 Trial.

Chen-Han Chueh, Wei-Ming Huang, Ming-Yu Hong

|Jun 24, 2024
The 2017 Women's Health Initiative study and use of hormone therapy: an emulated repeated cross-sectional study.

Chen-Han Chueh, Pei-Kuan Ho, Wai-Hou Li

|Sep 11, 2023
Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration.

Zi-Rong Chen, Chen-Han Chueh, Nai-Jung Chiang

Pageof 2

Frequent Collaborators

7 joint publications

Chen-Han Chueh

3 joint publications

Yu-Wen Wen

3 joint publications

Nai-Jung Chiang

2 joint publications

Zi-Rong Chen